Aducanumab

WMJ. 2022:121:P1.
No abstract available

MeSH terms

  • Alzheimer Disease*
  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • aducanumab